Activation of the complement system by polysaccharidic surfaces bearing carboxymethyl, carboxymethylbenzyl-amide and carboxymethylbenzylamide sulphonate groups
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Platelet Disorders and Treatments · Advanced Drug Delivery Systems · Complement system in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. Anaphylatoxin formation during hemodialysis: comparison of new and reused dialysers10.1038/ki.1983.226 ↗
2. Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyser cellophane membranes10.1172/JCI108710 ↗
3. Complement activation and cytokine production as consequences of immunological bioincompatibility of extracorporeal circuits10.1016/0267-6605(93)90017-2 ↗
4. Complement activation during hemodialysis: laboratory evaluation of hemodialyzers10.1111/j.1525-1594.1987.tb02649.x ↗
5. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces10.4049/jimmunol.123.3.1388 ↗
6. The human alternative complement pathway: biology and immunopathology of activation and regulation
7. The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives10.1016/0161-5890(88)90064-8 ↗
8. Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum10.1016/0142-9612(88)90047-6 ↗
9. Specific antibodies enhance alternative complement pathway activation by Cuprophan10.1093/ndt/6.3.193 ↗
10. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces10.1002/eji.1830191126 ↗
11. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle bound C3b10.1084/jem.150.5.1202 ↗
12. Anticomplementary activity of dextran derivatives10.1016/0142-9612(85)90040-7 ↗
13. Molecular weight dependence of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans10.1016/0142-9612(87)90111-6 ↗
14. Anticoagulant activity of dextran derivatives and characterization10.1016/0142-9612(84)90078-4 ↗
15. Anticoagulant activity of dextran derivatives. Part II. Mechanism of thrombin inactivation10.1016/0142-9612(85)90010-9 ↗
16. Antithrombic activity of some polysaccharide resins10.1016/0142-9612(82)90023-0 ↗
17. Complement and complement fixation
18. Techniques and significance of C3a and C5a measurements
19. Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum10.1016/0142-9612(92)90024-I ↗
20. Quantitative estimation of proteins by electrophoresis in agarose gels containing antibodies10.1016/0003-2697(66)90246-6 ↗
21. Specific interactions of polystyrene biomaterials with factor D of human complement10.1016/0142-9612(93)90065-A ↗
22. Activation of the alternative pathway of complement: efficient fluid-phase amplification by blockade of the regulatory complement protein β1H through sulfated polyanions10.1002/eji.1830110405 ↗
23. Interactions of functionalized polystyrene derivatives with the complement system in human serum10.1163/156856291X00034 ↗
24. Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces10.1016/0142-9612(93)90024-V ↗
25. Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface10.1016/0161-5890(93)90050-L ↗
26. Activation of complement in human serum by some synthetic polymers used for intraocular lenses10.1016/0142-9612(87)90116-5 ↗
27. Structure-function relationships in the inhibitory effect of heparin on complement activation: independency of the anticoagulant and anticomplementary sites on the heparin molecule10.1016/0161-5890(88)90130-7 ↗